Literature DB >> 22740117

Danazol-Induced Hepatocellular Carcinoma in a Patient with Hereditary Angioedema.

Muhammed Hameed Thoufeeq1, Javaid Ishtiaq2, Mohamed Abuzakouk3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22740117     DOI： 10.1007/s12029-012-9402-5

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  18 in total

1.  Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema.

Authors:  K Bork; M Pitton; P Harten; P Koch
Journal:  Lancet       Date:  1999-03-27       Impact factor: 79.321

2.  Danazol-induced hepatocellular carcinoma.

Authors:  C Confavreux; P Sève; C Broussolle; P Renaudier; C Ducerf
Journal:  QJM       Date:  2003-04

3.  Hepatocellular focal nodular hyperplasia after danazol treatment for hereditary angio-oedema.

Authors:  Per Helsing; Erik W Nielsen
Journal:  Acta Derm Venereol       Date:  2006       Impact factor: 4.437

4.  Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit.

Authors:  T Leese; O Farges; H Bismuth
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

5.  The effect of long-term danazol prophylaxis on liver function in hereditary angioedema-a longitudinal study.

Authors:  Henriette Farkas; Ibolya Czaller; Dorottya Csuka; Anikó Vas; Szilvia Valentin; Lilian Varga; Gábor Széplaki; László Jakab; George Füst; Zoltán Prohászka; George Harmat; Beata Visy; István Karádi
Journal:  Eur J Clin Pharmacol       Date:  2009-12-19       Impact factor: 2.953

6.  Androgen receptor in hepatocellular carcinoma as a prognostic factor after hepatic resection.

Authors:  N Nagasue; Y C Chang; T Hayashi; G Galizia; H Kohno; T Nakamura; H Yukaya
Journal:  Ann Surg       Date:  1989-04       Impact factor: 12.969

7.  Hepatocellular carcinoma after danazol therapy.

Authors:  B J Weill; C J Menkès; C Cormier; A Louvel; M Dougados; D Houssin
Journal:  J Rheumatol       Date:  1988-09       Impact factor: 4.666

Review 8.  Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions.

Authors:  Isela Velazquez; Blanche P Alter
Journal:  Am J Hematol       Date:  2004-11       Impact factor: 10.047

9.  Characterisation of a new C1 inhibitor mutant in a patient with hepatocellular carcinoma.

Authors:  Nicole Monnier; Denise Ponard; Christiane Duponchel; Françoise Csopaki; Laurence Bouillet; Mario Tosi; Joel Lunardi; Christian Drouet
Journal:  Mol Immunol       Date:  2006-03-10       Impact factor: 4.407

Review 10.  Hepatocellular carcinoma and sex hormones.

Authors:  N Nagasue; H Kohno
Journal:  HPB Surg       Date:  1992
View more
  2 in total

Review 1.  Pediatric hereditary angioedema.

Authors:  Andrew J MacGinnitie
Journal:  Pediatr Allergy Immunol       Date:  2013-12-09       Impact factor: 6.377

2.  Development of hepatocellular carcinoma after long-term immunosuppressive therapy including danazol in a dog.

Authors:  Kosuke Kobayashi; Takako Shimokawa Miyama; Kazuhito Itamoto; Shunsuke Noguchi; Kenji Baba; Takuya Mizuno; Masaru Okuda
Journal:  J Vet Med Sci       Date:  2016-06-20       Impact factor: 1.267
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.